Early trial tests drug to boost blood counts in cancer patients
NCT ID NCT04582539
Summary
This early-phase study tested a new drug called INCB000928 to see if it could safely treat anemia (low red blood cells) in people with myelodysplastic syndromes (MDS) or multiple myeloma. The main goals were to find a safe dose and see if the drug could reduce the need for blood transfusions or raise hemoglobin levels. The trial was small and ended early, so its effectiveness is not fully known.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Azienda Ospedaliero-Universitaria Careggi (Aouc)
Florence, 50134, Italy
-
Barbara Ann Karmanos Cancer Hospital
Detroit, Michigan, 48201, United States
-
Centre Hospitalier Universitaire de Nantes (Chu de Nantes) - Hotel-Dieu
Nantes, 44093, France
-
Comitato Di Bioetica Della Fondazione Irccs Policlinico San Matteo
Pavia, 27100, Italy
-
Florida Cancer Specialists
Sarasota, Florida, 34232, United States
-
Hospices Civils de Lyon Centre Hospitalier Lyon Sud
Pierre-Bénite, 69310, France
-
Institut Gustave Roussy
Villejuif, 94800, France
-
Irccs Istituto Clinico Humanitas
Rozzano, 20089, Italy
-
L Azienda Ospedaliero-Universitaria Di Bologna Policlinico S. Orsola - Malpighi
Bologna, 40138, Italy
-
Md Anderson Cancer Center
Houston, Texas, 77030, United States
-
Stanford Cancer Center
Palo Alto, California, 94304, United States
-
Tulane Comprehensive Cancer Center
New Orleans, Louisiana, 70112, United States
-
University of Cincinnati
Cincinnati, Ohio, 45219, United States
-
University of Miami
Miami, Florida, 33136, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.